Monday, 6 February 2012

Pharmaceutical Industry in India -CRAMS


CRAMS - Contract Research and Manufacturing Services
  • The Indian Pharmaceutical Industry is one of fastest emerging international center for contract research and manufacturing services or CRAMS
  • The main factors for the growth of the CRAMS is due to the international standard quality and low cost
  • The estimated value of the CRAMS market in 2006 was US$ 895 million
  • Indian already has the biggest number of US Food and Drug Administration (USFDA)
  • standardized manufacturing units outside the territory of United States
  • Around 50 more new manufacturing units are to be set up in accordance to the USFDA and UK Medicines and Healthcare Regulatory Agency (MHRA) standards
  • With all these development India is posed to become the biggest producer of drugs in the world
  • Some of the major domestic players in this sector are Paras Pharma, Bal Pharma, Unijules Life Sciences, Flamingo Pharma, Venus Remedies, Surya Organics and Chemicals, Centaur Pharma, Kemwell, Coral Labs
  • The contract manufacturing market in India pertaining to the multinational companies is expected to worth US$ 900 million by the year 2010
Posted by
Labels: , , , ,

2 comments:

  1. preeti4 April 2012 at 16:53

    Very nice informative post that is about Indian Pharma companies. Indian pharma companies has shown great potential to grow in the recent past years.


    --------------------------------

    Molybdenum suppliers

    ReplyDelete
  2. Optim Pharma6 April 2012 at 15:58

    Thanks Preeti,

    yes especially after availing contract research many small companies with limited resources have been able to expand....

    ReplyDelete

Subscribe to: Post Comments (Atom)